Karius Inc.

About Karius Inc.

Karius is a life-sciences company that developed a non-invasive blood test based on next-generation sequencing to detect over 1,000 pathogens from a single sample. The test helps physicians diagnose infectious diseases in immunocompromised patients, guiding targeted treatment and reducing empirical antibiotic use. The company operates a CLIA-certified and CAP-accredited laboratory, providing results within one day. Its proprietary microbial cell-free DNA technology aims to improve patient outcomes by enabling earlier, more accurate identification of infections across hospitals and health systems in the United States.